Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1131321

	registered interest
	date	11/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress he has made on ensuring that medical cannabis is available to people who need it.
	tabling member constituency	Birkenhead
	tabling member printed	Frank Field
	uin	263063
	answer	answer is ministerial correction date of answer 19/06/2019 answer text <p>The law was changed on 1 November 2018 to allow clinicians on the General Medical Council’s ‘Specialist Register’ to prescribe cannabis-based products for medicinal use, where clinically appropriate and in the best interest of patients.</p><p>Interim clinical guidance has been issued by the Royal College of Physicians, the British Paediatric Neurology Association and the Association of British Neurologists to support doctors looking to prescribe cannabis-based products. The National Institute for Health and Care Excellence (NICE) has been commissioned to develop updated clinical guidance on the prescribing of cannabis-based medicinal products, which will be published by October 2019. It will be based on the best available international evidence and will have been produced using NICE’s world-renowned process for delivering such guidance.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 19/06/2019 14:21:18 answering member 4455 label Biography information for Seema Kennedy
	tabling member	478 label Biography information for Lord Field of Birkenhead

1128815

	registered interest
	date	03/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that all patients who would benefit from medical cannabis are able to access that treatment on prescription on the NHS.
	tabling member constituency	Birkenhead
	tabling member printed	Frank Field
	uin	259011
	answer	answer is ministerial correction date of answer 11/06/2019 answer text <p>Cannabis-based products for medicinal use are no different from other medicines, and existing systems for the funding of both licensed and unlicensed medicines apply.</p><p>Any medicines which receive a marketing authorisation from the Medicines and Healthcare Products Regulatory Agency or European Medicines Agency will be assessed for cost effectiveness by the National Institute for Health and Care Excellence. This is the foundation of National Health Service decisions about routine funding, and applies to all licensed medicines. For unlicensed medicines, the normal NHS medicines governance systems apply, as they do to all locally funded unlicensed treatments. These processes support good clinical practice and safe and effective prescribing. Decisions will be taken, at NHS Trust level on a case by case basis, based on the needs of the individual patient and the evidence of efficacy and cost effectiveness available.</p><p>My Rt. hon. Friend the Secretary of State for Health and Social Care has heard patients report difficulties in accessing medicinal cannabis. As a result, he asked the Department to work closely with NHS England to undertake a rapid process evaluation. This is underway and will review NHS system processes to identify and make recommendations to address any barriers to clinically appropriate prescribing, should they exist.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 11/06/2019 16:52:22 answering member 4455 label Biography information for Seema Kennedy
	tabling member	478 label Biography information for Lord Field of Birkenhead

1063970

	registered interest
	date	19/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to prevent patients from being incorrectly denied access to medicinal cannabis.
	tabling member constituency	Birkenhead
	tabling member printed	Frank Field
	uin	223142
	answer	answer is ministerial correction date of answer 27/02/2019 answer text <p>The decision to prescribe a cannabis-based product for medicinal use is one for individual clinicians to make, as part of a multidisciplinary team and in partnership with patients and their families.</p><p> </p><p>It would be inappropriate to second-guess the prescribing decisions of clinicians, who will be experts in their area and bear responsibility for prescribing.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 27/02/2019 16:19:18 answering member 4067 label Biography information for Steve Brine
	tabling member	478 label Biography information for Lord Field of Birkenhead

1005764

	registered interest
	date	12/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the effectiveness of NHS and medical professional body guidelines on the prescription of medicinal cannabis in ensuring the eligibility for prescription of patients for whom that treatment might be advantageous.
	tabling member constituency	Birkenhead
	tabling member printed	Frank Field
	uin	190361
	answer	answer is ministerial correction date of answer 15/11/2018 answer text <p>The Medical Director of NHS England, Professor Steve Powis, and the Chief Medical Officer, Professor Dame Sally Davies, have written to relevant clinicians to coincide with the coming into force of the rescheduling of cannabis-based medicinal products. The guidance in this letter, which signposts interim clinical advice commissioned from the British Paediatric Neurology Association and the Royal College of Physicians, is in line with normal clinical practice. The decision to prescribe cannabis-based products for medicinal use will be made on a case-by-case basis, based on clinical need and in-line with existing governance procedures for prescribing unlicensed medicines.</p><p> </p><p>The Department has commissioned the National Institute for Health and Care Excellence to produce clinical guidance by October 2019, which will update and replace the interim advice.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/11/2018 12:47:21 answering member 4067 label Biography information for Steve Brine
	tabling member	478 label Biography information for Lord Field of Birkenhead

933893

	registered interest
	date	02/07/2018
	answering body	Home Office
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for the Home Department, what progress has been made on the issuing of a licence to Billy Caldwell for medicinal cannabis.
	tabling member constituency	Birkenhead
	tabling member printed	Frank Field
	uin	159519
	answer	answer is ministerial correction date of answer 05/07/2018 answer text <p>As you will be aware on the weekend of 16 -17 June the Home Secretary issued an emergency licence to Billy Caldwell to access a schedule 1 controlled drug.</p><p>This particular licence was issued as a short-term solution based on the urgency of the case and currently remains valid. For the longer term, either the Home Office or the Department of Health in Northern Ireland will need to consider a full Schedule 1 application from a senior specialist clinician. This can only happen if this is the course of action recommended by Billy Caldwell’s medical team.</p><p>The expert panel that has been established to consider applications to prescribe cannabis and cannabis based medicinal products is now operational and in a position to start considering applications.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 05/07/2018 15:13:03 answering member 1561 label Biography information for Mr Nick Hurd
	tabling member	478 label Biography information for Lord Field of Birkenhead